Perspective Therapeutics Inc (AMEX: CATX) on Friday, plunged -3.03% from the previous trading day, before settling in for the closing price of $11.89. Within the past 52 weeks, CATX’s price has moved between $2.20 and $19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 46.36%. With a float of $48.31 million, this company’s outstanding shares have now reached $67.43 million.
In an organization with 119 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 3.58%, operating margin of -642.65%, and the pretax margin is -621.47%.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 28.35%, while institutional ownership is 51.94%. The most recent insider transaction that took place on Sep 12 ’24, was worth 39,500. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Financial Officer bought 1,800 for $9.81, making the entire transaction worth $17,667. This insider now owns 35,971 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 46.36% per share during the next fiscal year.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 27.73 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 87.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.51 million. That was inferior than the volume of 0.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.96%. Additionally, its Average True Range was 0.83.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 40.17%, which indicates a significant decrease from 49.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.65% in the past 14 days, which was lower than the 81.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.72, while its 200-day Moving Average is $12.42. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $11.83. Second resistance stands at $12.12. The third major resistance level sits at $12.29. If the price goes on to break the first support level at $11.37, it is likely to go to the next support level at $11.20. The third support level lies at $10.91 if the price breaches the second support level.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 777.47 million based on 62,263K outstanding shares. Right now, sales total 1,430 K and income totals -46,510 K. The company made 530 K in profit during its latest quarter, and -11,700 K in sales during its previous quarter.
